Education
About Us
Working with TipRanks
Follow Us
Suven Pharmaceuticals Ltd. (IN:SUVENPHAR)
:SUVENPHAR
Summary of all the Indicators
Overall Consensus
Sell
6Bullish
0Neutral
16Bearish
Technical Analysis Consensus
Buy
6Bullish
0Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) Moving Averages Convergence Divergence (MACD) indicator is -74.06, suggesting Suven Pharmaceuticals Ltd. is a Buy.
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) 20-Day exponential moving average is 666.63, while Suven Pharmaceuticals Ltd.’s (SUVENPHAR) share price is ₹891.1, making it a Sell.
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) 50-Day exponential moving average is 771.87, while Suven Pharmaceuticals Ltd.’s (SUVENPHAR) share price is ₹891.1, making it a Sell.
Suven Pharmaceuticals Ltd. (SUVENPHAR) Pivot Points
Classic
537.45
551.25
561.05
574.85
584.65
598.45
608.25
Fibonacci
551.25
560.27
565.83
574.85
583.87
589.43
598.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Suven Pharmaceuticals Ltd. (SUVENPHAR) Moving Averages
MA5
576.80Sell
579.30Sell
MA10
602.55Sell
608.35Sell
MA20
675.52Sell
666.63Sell
MA50
808.43Sell
771.87Sell
MA100
890.80Sell
859.76Sell
MA200
996.20Sell
968.15Sell
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) 10-Day exponential moving average is 608.35, while Suven Pharmaceuticals Ltd.’s (SUVENPHAR) share price is ₹891.1, making it a Sell.
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) 100-Day exponential moving average is 859.76, while Suven Pharmaceuticals Ltd.’s (SUVENPHAR) share price is ₹891.1, making it a Sell.
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) stock price is ₹891.1 and Suven Pharmaceuticals Ltd.’s (SUVENPHAR) 50-day simple moving average is 808.43, creating a Sell signal.
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) stock price is ₹891.1 and Suven Pharmaceuticals Ltd.’s (SUVENPHAR) 100-day simple moving average is 890.80, creating a Sell signal.
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) stock price is ₹891.1 and Suven Pharmaceuticals Ltd.’s (SUVENPHAR) 200-day simple moving average is 996.20, creating a Sell signal.
Suven Pharmaceuticals Ltd. (SUVENPHAR) Technical Indicators
RSI (14)
12.62
Buy
STOCH (9,6)
6.00
Buy
STOCHRSI (14)
4.29
Buy
MACD (12,26)
-74.06
Buy
ADX (14)
55.12
Sell
Williams %R
-98.11
Buy
CCI (14)
-104.27
Buy
ATR (14)
25.94
-
Ultimate Oscillator
24.62
Sell
ROC
-24.44
Sell
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) Relative Strength Index (RSI) is 12.62, creating a Buy signal.
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) Trend Strength Indicator (ADX) is 55.12, creating a Sell signal.
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) Commodity Channel Index (CCI) is -104.27, creating a Buy signal.
Suven Pharmaceuticals Ltd.’s (SUVENPHAR) Price Rate of Change (ROC) is -24.44, creating a Sell signal.
FAQ
Is SUVENPHAR a Buy, Hold, or Sell?
Based on SUVENPHAR’s technical indicators, SUVENPHAR is a Sell.
What is SUVENPHAR’s RSI (14)?
SUVENPHAR’s RSI (14) is 12.62, which suggests SUVENPHAR is a Buy.
What is SUVENPHAR’s MACD?
SUVENPHAR’s MACD is -74.06, which suggests SUVENPHAR is a Buy.
What is SUVENPHAR’s 5-day moving average?
SUVENPHAR’s 5-day moving average is 576.80, which suggests SUVENPHAR is a Sell.
What is SUVENPHAR’s 20-day moving average?
SUVENPHAR 20-day moving average is 675.52, which suggests SUVENPHAR is a Sell.
What is SUVENPHAR’s 50-day moving average?
SUVENPHAR’s 50-day moving average is 808.43, which suggests SUVENPHAR is a Sell.
What is SUVENPHAR’s 200-day moving average?
SUVENPHAR’s 200-day moving average is 996.20, which suggests SUVENPHAR is a Sell.
What is SUVENPHAR’s Williams % R (14)?
SUVENPHAR’s Williams % R (14) is -98.11, which suggests SUVENPHAR is a Buy.
What is SUVENPHAR’s CCI (14)?
SUVENPHAR’s CCI (14) is -104.27, which suggests SUVENPHAR is a Buy.
What is the share price of Suven Pharmaceuticals Ltd.?